Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR-18.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-18.1%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 46.03% |
| 2024 | 22.69% |
| 2023 | -1.27% |
| 2022 | -136.74% |
| 2021 | -670.07% |
| 2020 | 124.90% |
| 2019 | -17.89% |
| 2018 | 1.61% |
| 2017 | 0.61% |
| 2016 | -41.85% |